Prostate Cancer- New Treatment - Clinical Presentation


Prostatic cancer (PCa) is the most frequent cancer in Europe in men over 70 years-old and the most commonly diagnosed non-skin cancer in men in the United States. PCa follows lung cancer in annual fatality rate, with a lifelong risk for diagnosis of 15.9%(1,2). Over 200.000 new cases are diagnosed each year with approximately one in every six U.S. men affected by the disease. Histology studies from autopsy series show that about 33% of men between 40 and 60 years-old have prostate cancer (3). The incidence of PCa increases with age and reaches 75% in men older than 85 years (4).



Prostate cancer may not have any clinical symptoms. Some cases may have urinary symptoms due to benign prostatic hyperplasia associated to prostate cancer. Elevated PSA may be the single suspicious sign of prostate cancer. PCA may occur in patients with PSA below 2.             

Partilhe este conteúdo

Comments are closed.